Bach Option’s Gilead Sciences GILD Stock Holding History

Bach Option’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,000	Closed	-$626K	–	114
2018 Q4	$626K	Sell	10,000 -2,500	-20%	-$175K	0.16%	84
2018 Q3	$965K	Sell	12,500 -3,500	-22%	-$264K	0.31%	53
2018 Q2	$1.13M	Buy	+16,000	New	+$1.13M	0.54%	29
2017 Q3	–	Sell	-15,500	Closed	-$1.1M	–	104
2017 Q2	$1.1M	Sell	15,500 -3,000	-16%	-$200K	1.03%	23
2017 Q1	$1.26M	Buy	18,500 +1,500	+9%	+$105K	0.95%	20
2016 Q4	$1.22M	Buy	17,000 +5,000	+42%	+$372K	0.55%	40
2016 Q3	$949K	Buy	12,000 +1,000	+9%	+$81.2K	0.44%	59
2016 Q2	$918K	Sell	11,000 -4,000	-27%	-$355K	0.37%	63
2016 Q1	$1.38M	Buy	+15,000	New	+$1.35M	0.83%	14

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bach Option's GILD Position: Q2 2017 in Review

Bach Option sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 3,126 shares — an estimated $208K sold.

Bach Option first reported a position in GILD in Q1 2016 and held it in 4 quarters. The position peaked at $494K in Q4 2016. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

Bach Option reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
Bach Option sold 3,126 Gilead Sciences shares in Q2 2017, an estimated $208K.
Bach Option first reported a position in Gilead Sciences in Q1 2016 and held it in 4 quarters.
Bach Option's Gilead Sciences position peaked at $494K in Q4 2016.
1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Bach Option's 13F filing for Q2 2017, filed 13 Jul 2017.